Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adolescent 3
- Adult 3
- Aged 1
- Animals 1
- Antibodies, Protozoan 1
- antigen detection 1
- Antigens, Protozoan 3
- Antimalarials 2
- Article 2
- Base Sequence 1
- BetacoronaVirus 1
- Child 4
- Child, Preschool 3
- Cluster Analysis 1
- Communicable Disease Control 1
- CoronaVirus Infections 2
- COVID-19 2
- Cross-Sectional Studies 3
- Cyclospora 2
- Cyclosporiasis 1
- Data Collection 1
- dendrogram 1
- Diagnostic Tests, Routine 3
- dihydrofolate reductase 1
- Disease Outbreaks 1
- DNA, Protozoan 1
- DNA, Ribosomal 1
- Dried Blood Spot Testing 1
- Drug Monitoring 1
- Drug Resistance 2
- drug resistance 1
- Elephantiasis, Filarial 1
- Enzyme-Linked Immunosorbent Assay 1
- Epidemics 1
- Family Characteristics 1
- Female 4
- Fever 1
- framework 1
- Full Report 1
- genetic distance 1
- Genotype 1
- Global Health 2
- Government Programs 1
- Haplotypes 1
- Health Facilities 2
- Health Personnel 1
- Hemorrhagic Fever, Ebola 1
- hierarchical clustering 1
- Humans 9
- Immunoassay 1
- Infant 2
- Insecticide-Treated Bednets 1
- Insecticides 1
- Interviews as Topic 1
- Longitudinal Studies 1
- Major Articles 1
- Malaria 4
- malaria 2
- Malaria, Falciparum 5
- Malaria, Vivax 1
- Malarone 1
- Male 4
- Mass Drug Administration 1
- Middle Aged 3
- Mosquito Control 1
- MSP119 1
- Multilocus Sequence Typing 1
- Multiplex 1
- multiplex immunoassay 1
- Mutation 1
- non-falciparum malaria 1
- Nucleotides 1
- outbreaks 1
- Parasites 1
- Pfhrp2 deletion 1
- Phylogeny 1
- Plasmodium 1
- Plasmodium falciparum 3
- Plasmodium Falciparum 1
- Pneumonia, Viral 1
- Polymerase Chain Reaction 2
- Protozoan Proteins 5
- Public Health Practice 1
- Public Health Surveillance 1
- Registries 1
- Research 4
- Research Article 1
- Retrospective Studies 1
- Risk Factors 1
- SARS-CoV-2 1
- Sensitivity and Specificity 1
- Sequence Deletion 1
- Seroconversion 1
- Serology 1
- Ships 2
- Specificity 1
- Surveys and Questionnaires 1
- Time Factors 1
- Travel-Related Illness 1
- Young Adult 3
Personal Author
Corporate Author
Place as Subject
- Africa 1
- Angola 1
- Guinea 1
- Haiti 2
- Kenya 1
- Mozambique 2
- Nigeria 1
- Senegal 1
- Tanzania 1
- United States 2
Resource Type General
Keywords
- antigen concentration 1
- Antimalarial resistance 1
- Antimalarials 1
- Artemether 1
- Artemether, Lumefantrine Drug Combination 1
- artemether-lumefantrine 1
- artemisinin-based combination therapy 1
- Drug Combinations 1
- efficacy monitoring 1
- Ethanolamines 1
- Fluorenes 1
- Humans 1
- Lumefantrine 1
- Malaria 1
- Malaria, Falciparum 1
- Plasmodium falciparum 1
- resistance 1
- traveller 1
- Treatment Failure 1
Select all docs (Max 200)
1 -
19 of 19 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adolescent (3)
- Adult (3)
- Aged (1)
- Animals (1)
- Antibodies, Protozoan (1)
- antigen detection (1)
- Antigens, Protozoan (3)
- Antimalarials (2)
- Article (2)
- Base Sequence (1)
- BetacoronaVirus (1)
- Child (4)
- Child, Preschool (3)
- Cluster Analysis (1)
- Communicable Disease Control (1)
- CoronaVirus Infections (2)
- COVID-19 (2)
- Cross-Sectional Studies (3)
- Cyclospora (2)
- Cyclosporiasis (1)
- Data Collection (1)
- dendrogram (1)
- Diagnostic Tests, Routine (3)
- dihydrofolate reductase (1)
- Disease Outbreaks (1)
- DNA, Protozoan (1)
- DNA, Ribosomal (1)
- Dried Blood Spot Testing (1)
- Drug Monitoring (1)
- Drug Resistance (2)
- drug resistance (1)
- Elephantiasis, Filarial (1)
- Enzyme-Linked Immunosorbent Assay (1)
- Epidemics (1)
- Family Characteristics (1)
- Female (4)
- Fever (1)
- framework (1)
- Full Report (1)
- genetic distance (1)
- Genotype (1)
- Global Health (2)
- Government Programs (1)
- Haplotypes (1)
- Health Facilities (2)
- Health Personnel (1)
- Hemorrhagic Fever, Ebola (1)
- hierarchical clustering (1)
- Humans (9)
- Immunoassay (1)
- Infant (2)
- Insecticide-Treated Bednets (1)
- Insecticides (1)
- Interviews as Topic (1)
- Longitudinal Studies (1)
- Major Articles (1)
- Malaria (4)
- malaria (2)
- Malaria, Falciparum (5)
- Malaria, Vivax (1)
- Malarone (1)
- Male (4)
- Mass Drug Administration (1)
- Middle Aged (3)
- Mosquito Control (1)
- MSP119 (1)
- Multilocus Sequence Typing (1)
- Multiplex (1)
- multiplex immunoassay (1)
- Mutation (1)
- non-falciparum malaria (1)
- Nucleotides (1)
- outbreaks (1)
- Parasites (1)
- Pfhrp2 deletion (1)
- Phylogeny (1)
- Plasmodium (1)
- Plasmodium falciparum (3)
- Plasmodium Falciparum (1)
- Pneumonia, Viral (1)
- Polymerase Chain Reaction (2)
- Protozoan Proteins (5)
- Public Health Practice (1)
- Public Health Surveillance (1)
- Registries (1)
- Research (4)
- Research Article (1)
- Retrospective Studies (1)
- Risk Factors (1)
- SARS-CoV-2 (1)
- Sensitivity and Specificity (1)
- Sequence Deletion (1)
- Seroconversion (1)
- Serology (1)
- Ships (2)
- Specificity (1)
- Surveys and Questionnaires (1)
- Time Factors (1)
- Travel-Related Illness (1)
- Young Adult (3)
- antigen concentration (1)
- Antimalarial resistance (1)
- Antimalarials (1)
- Artemether (1)
- Artemether, Lumefantrine Drug Combination (1)
- artemether-lumefantrine (1)
- artemisinin-based combination therapy (1)
- Drug Combinations (1)
- efficacy monitoring (1)
- Ethanolamines (1)
- Fluorenes (1)
- Humans (1)
- Lumefantrine (1)
- Malaria (1)
- Malaria, Falciparum (1)
- Plasmodium falciparum (1)
- resistance (1)
- traveller (1)
- Treatment Failure (1)
- :Talundzic, Eldin ;Okoth, Sheila AkinyiApr 02 2015 | PLoS Pathog. 11(4).:The recent emergence of artemisinin resistance in the Greater Mekong Subregion poses a major threat to the global effort to control malaria. Tracking ...
- :Plucinski, Mateusz M. ;Ferreira, ManzambiMay 03 2017 | Malar J. 16.:BackgroundMalaria accounts for the largest portion of healthcare demand in Angola. A pillar of malaria control in Angola is the appropriate management...
- :Plucinski, Mateusz M. ;Herman, CameliaJan 09 2019 | J Infect Dis. 219(3):437-447:Background.Detection of Plasmodium antigens provides evidence of malaria infection status and is the basis for most malaria diagnosis.Methods.We devel...
- :Priest, Jeffrey W. ;Plucinski, Mateusz M.Nov 09 2018 | Malar J. 17.:BackgroundMultiplex bead assays (MBA) that measure IgG antibodies to the carboxy-terminal 19-kDa sub-unit of the merozoite surface protein 1 (MSP119) ...
- :Plucinski, Mateusz M. ;Dimbu, Pedro RafaelFeb 02 2017 | Malar J. 16.:BackgroundRecent anti-malarial resistance monitoring in Angola has shown efficacy of artemether–lumefantrine (AL) in certain sites approaching the k...
- :Jacobson, David ;Zheng, Yueli12 2022 | Mol Phylogenet Evol. 177:107608:Multi-locus sequence typing (MLST) is widely used to investigate genetic relationships among eukaryotic taxa, including parasitic pathogens. MLST anal...
- :Barratt, Joel L. N. ;Plucinski, Mateusz M.5 05 2023 | Am J Epidemiol. 192(5):772-781:Comparing parasite genotypes to inform parasitic disease outbreak investigations involves computation of genetic distances that are typically analyzed...
- :Schmedes, Sarah E. ;Patel, DhruvibenJuly 2021 | Emerg Infect Dis. 27(7):1902-1908:The spread of drug resistance to antimalarial treatments poses a serious public health risk globally. To combat this risk, molecular surveillance of d...
- :Herman, Camelia ;Huber, Curtis S.November 27 2019 | Malar J. 18:BackgroundThe Plasmodium falciparum parasite is the only human malaria that produces the histidine-rich protein 2 and 3 (HRP2/3) antigens. Currently, ...
- :Plucinski, Mateusz M. ;Huber, Curtis S.Aug 05 2014 | Open Forum Infect Dis. 2014; 1(2).:Background Atovaquone-proguanil (AP) is the most commonly used treatment for uncomplicated Plasmodium falciparum malaria in the United States. Appar...
- :Colborn, James M. ;Zulliger, RoseApril 20 2020 | PLoS One. 2020; 15(4):BackgroundMalaria data reported through Mozambique’s routine health information system are used to guide the implementation of prevention and contro...
- :Plucinski, Mateusz M. ;Candrinho, BaltazarFeb 14 2018 | PLoS Negl Trop Dis. 12(2).:BackgroundUniversal coverage with long-lasting insecticidal nets (LLINs) is a primary control strategy against Plasmodium falciparum malaria. However,...
- :Rogier, Eric ;Hamre, Karen E. S.February 18 2020 | J Infect Dis. 221(5):786-795:Accurate malaria diagnosis is foundational for control and elimination, and Haiti relies on histidine-rich protein 2 (HRP2)-based rapid diagnostic tes...
- :Halsey, Eric S. ;Venkatesan, MeeraDec 2017 | Emerg Infect Dis. 23(Suppl 1):S53-S56.:Antimalarial drug resistance is an evolving global health security threat to malaria control. Early detection of Plasmodium falciparum resistance thro...
- :Hennessee, Ian ;Guilavogui, TimothéeJune 14 2018 | Malar J. 17:BackgroundMalaria case management in the context of the 2014–2016 West African Ebola virus disease (EVD) epidemic was complicated by a similar initi...
- :Plucinski, Mateusz M. ;Rafael Dimbu, Pedro2 14 2018 | J Infect Dis. 217(5):685-692:Background.The response to antimalarial treatment is assessed using serial microscopy. New techniques for accurate measurement of the Plasmodium falci...
- :Moriarty, Leah F. ;Plucinski, Mateusz M.March 27 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):An estimated 30 million passengers are transported on 272 cruise ships Worldwide each year* (1). Cruise ships bring diverse populations into proximity...
- :Moriarty, Leah F. ;Plucinski, Mateusz M.March 23, 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Please note: This report has been corrected.What is already known about this topic?: Cruise ships are often settings for outbreaks of infectious Disea...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.